335 related articles for article (PubMed ID: 31088830)
1. Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer.
Chera BS; Kumar S; Beaty BT; Marron D; Jefferys S; Green R; Goldman EC; Amdur R; Sheets N; Dagan R; Hayes DN; Weiss J; Grilley-Olson JE; Zanation A; Hackman T; Blumberg JM; Patel S; Weissler M; Tan XM; Parker JS; Mendenhall W; Gupta GP
Clin Cancer Res; 2019 Aug; 25(15):4682-4690. PubMed ID: 31088830
[TBL] [Abstract][Full Text] [Related]
2. Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer.
Chera BS; Kumar S; Shen C; Amdur R; Dagan R; Green R; Goldman E; Weiss J; Grilley-Olson J; Patel S; Zanation A; Hackman T; Blumberg J; Patel S; Thorp B; Weissler M; Yarbrough W; Sheets N; Mendenhall W; Tan XM; Gupta GP
J Clin Oncol; 2020 Apr; 38(10):1050-1058. PubMed ID: 32017652
[TBL] [Abstract][Full Text] [Related]
3. Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell Disease.
Lam D; Sangal NR; Aggarwal A; Rajasekaran K; Cannady SB; Basu D; Chalian A; Weinstein G; Brody RM
JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):444-450. PubMed ID: 38573644
[TBL] [Abstract][Full Text] [Related]
4. Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary.
Tanaka H; Suzuki M; Takemoto N; Fukusumi T; Eguchi H; Takai E; Kanai H; Tatsumi M; Horie M; Takenaka Y; Yachida S; Inohara H
Int J Cancer; 2022 Jan; 150(1):174-186. PubMed ID: 34486724
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
[TBL] [Abstract][Full Text] [Related]
6. HPV circulating tumoral DNA quantification by droplet-based digital PCR: A promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
Veyer D; Wack M; Mandavit M; Garrigou S; Hans S; Bonfils P; Tartour E; Bélec L; Wang-Renault SF; Laurent-Puig P; Mirghani H; Rance B; Taly V; Badoual C; Péré H
Int J Cancer; 2020 Aug; 147(4):1222-1227. PubMed ID: 31756275
[TBL] [Abstract][Full Text] [Related]
7. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
8. Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma.
Hanna GJ; Sridharan V; Margalit DN; La Follette SK; Chau NG; Rabinowits G; Lorch JH; Haddad RI; Tishler RB; Anderson KS; Schoenfeld JD
Cancer Biomark; 2017; 19(2):129-136. PubMed ID: 28387659
[TBL] [Abstract][Full Text] [Related]
9. It is time to improve the diagnostic workup of oropharyngeal cancer with circulating tumor HPV DNA: Systematic review and meta-analysis.
Paolini F; Campo F; Iocca O; Manciocco V; De Virgilio A; De Pascale V; Moretto S; Dalfino G; Vidiri A; Blandino G; Pimpinelli F; Venuti A; Pellini R
Head Neck; 2023 Nov; 45(11):2945-2954. PubMed ID: 37715656
[TBL] [Abstract][Full Text] [Related]
10. OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer.
Seiwert TY; Foster CC; Blair EA; Karrison TG; Agrawal N; Melotek JM; Portugal L; Brisson RJ; Dekker A; Kochanny S; Gooi Z; Lingen MW; Villaflor VM; Ginat DT; Haraf DJ; Vokes EE
Ann Oncol; 2019 Feb; 30(2):297-302. PubMed ID: 30481287
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor HPV DNA complements PET-CT in guiding management after radiotherapy in HPV-related squamous cell carcinoma of the head and neck.
Tanaka H; Takemoto N; Horie M; Takai E; Fukusumi T; Suzuki M; Eguchi H; Komukai S; Tatsumi M; Isohashi F; Ogawa K; Yachida S; Inohara H
Int J Cancer; 2021 Feb; 148(4):995-1005. PubMed ID: 32895945
[TBL] [Abstract][Full Text] [Related]
12. Assessing the feasibility of a multimodal liquid biopsy for the diagnosis of HPV-associated oropharyngeal squamous cell carcinoma.
Lewis JS; Naegele S; Efthymiou V; Mehrad M; Ely KA; Waterboer T; Lang Kuhs KA; Davis SJ; Richard K; Das D; Faden DL
Am J Clin Pathol; 2024 Jun; 161(6):570-578. PubMed ID: 38349613
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma.
Cabel L; Jeannot E; Bieche I; Vacher S; Callens C; Bazire L; Morel A; Bernard-Tessier A; Chemlali W; Schnitzler A; Lièvre A; Otz J; Minsat M; Vincent-Salomon A; Pierga JY; Buecher B; Mariani P; Proudhon C; Bidard FC; Cacheux W
Clin Cancer Res; 2018 Nov; 24(22):5767-5771. PubMed ID: 30054279
[No Abstract] [Full Text] [Related]
14. Transitions in oral and gut microbiome of HPV+ oropharyngeal squamous cell carcinoma following definitive chemoradiotherapy (ROMA LA-OPSCC study).
Oliva M; Schneeberger PHH; Rey V; Cho M; Taylor R; Hansen AR; Taylor K; Hosni A; Bayley A; Hope AJ; Bratman SV; Ringash J; Singh S; Weinreb I; Perez-Ordoñez B; Chepeha D; Waldron J; Xu W; Guttman D; Siu LL; Coburn B; Spreafico A
Br J Cancer; 2021 Apr; 124(9):1543-1551. PubMed ID: 33750907
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor HPV DNA assessments after surgery for human papilloma virus-associated oropharynx carcinoma.
Souza SS; Stephens EM; Bourdillon AT; Bhethanabotla R; Farzal Z; Plonowska-Hirschfeld K; Qualliotine JR; Heaton CM; Ha PK; Ryan WR
Am J Otolaryngol; 2024; 45(2):104184. PubMed ID: 38101135
[TBL] [Abstract][Full Text] [Related]
16. Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer.
Hanna GJ; Lau CJ; Mahmood U; Supplee JG; Mogili AR; Haddad RI; Jänne PA; Paweletz CP
Oral Oncol; 2019 Aug; 95():120-126. PubMed ID: 31345379
[TBL] [Abstract][Full Text] [Related]
17. HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancer.
Cabel L; Bonneau C; Bernard-Tessier A; Héquet D; Tran-Perennou C; Bataillon G; Rouzier R; Féron JG; Fourchotte V; Le Brun JF; Benoît C; Rodrigues M; Scher N; Minsat M; Legrier ME; Bièche I; Proudhon C; Sastre-Garau X; Bidard FC; Jeannot E
ESMO Open; 2021 Jun; 6(3):100154. PubMed ID: 34022731
[TBL] [Abstract][Full Text] [Related]
18. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
[TBL] [Abstract][Full Text] [Related]
19. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009).
Rodrigo JP; Heideman DA; García-Pedrero JM; Fresno MF; Brakenhoff RH; Díaz Molina JP; Snijders PJ; Hermsen MA
Int J Cancer; 2014 Jan; 134(2):487-92. PubMed ID: 23824638
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
